FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981839969> ?p ?o ?g. }

• W2981839969 abstract "Abstract Introduction The platelet P2Y12 antagonist ticagrelor reduces all-cause and cardiovascular mortality in patients after acute myocardial infarction (AMI) compared to clopidogrel, but the underlying mechanism is unknown. Because activated platelets release prothrombotic extracellular vesicles (EVs) exposing P-selectin, fibrinogen and phosphatidylserine (PS), we hypothesized that ticagrelor inhibits the release of EVs compared to clopidogrel. Purpose To compare the effects of ticagrelor and clopidogrel on the concentrations of platelet EVs in relation to platelet reactivity, and on the concentrations of EVs from other P2Y12-exposing cells (leukocytes, endothelial cells). Methods After the percutaneous coronary intervention, patients with first AMI (n=60, age 64.5±10.8 years, 68% male) were randomized in 1:1 ratio to antiplatelet therapy with ticagrelor or clopidogrel. Venous blood was collected from fasting patients at randomisation, 48 hours after randomisation, and 6 months following the index hospitalization with informed consent. Flow cytometry (Apogee A60 Micro) was used to determine plasma concentrations of EVs labelled with antibodies for activated platelets (CD61, CD62p; PEVs), fibrinogen, phosphatidylserine (PS), leukocytes (CD45; LEVs) and endothelial cells (CD146; EEVs). To maximize the reliability, the analysis of the 1,224 flow cytometry data files was performed with software enabling automatic flow rate stabilization, diameter and refractive index determination, size distribution fitting, fluorescent gate determination, and statistics reporting (MATLAB R2018a). To differentiate between EVs and small platelets, only particles <700 nm were included. Platelet reactivity was assessed by impedance aggregometry (Multiplate Analyzer) using the ASPI test (arachidonic acid, 0.5 mM) and the ADP test (adenosine diphosphate, 6.5 μM). Results Concentrations of PEVs exposing P-selectin, fibrinogen and PS were lower after 6 months of therapy with ticagrelor compared to clopidogrel, and decreased over time (p=0.034; p=0.021; p=0.018, respectively). Concentrations of LEVs were lower both after 72 hours and after 6 months of therapy with ticagrelor compared to clopidogrel (p=0.018; p<0.001, respectively). There was a trend towards higher concentrations of EEVs both after 72 hours and after 6 months of therapy with ticagrelor, compared to clopidogrel. There were no correlations between the concentrations of PEVs and platelet reactivity. Conclusions Ticagrelor decreases concentrations of prothrombotic EVs, compared to clopidogrel, suggesting that the clinical benefits of ticagrelor may be at least partly explained by inhibition of EV release from activated platelets. Further research is warranted to link this effect with clinical outcomes. Acknowledgement/Funding Medical University of Warsaw (1WR/PM2/18)" @default.
• W2981839969 created "2019-11-01" @default.
• W2981839969 creator A5004391058 @default.
• W2981839969 creator A5007660537 @default.
• W2981839969 creator A5011053615 @default.
• W2981839969 creator A5018345279 @default.
• W2981839969 creator A5023260832 @default.
• W2981839969 creator A5034576499 @default.
• W2981839969 creator A5046792925 @default.
• W2981839969 creator A5048001360 @default.
• W2981839969 creator A5050576957 @default.
• W2981839969 creator A5051409613 @default.
• W2981839969 creator A5055422464 @default.
• W2981839969 creator A5059132544 @default.
• W2981839969 creator A5072012682 @default.
• W2981839969 creator A5074510402 @default.
• W2981839969 date "2019-10-01" @default.
• W2981839969 modified "2023-09-26" @default.
• W2981839969 title "257Ticagrelor decreases concentrations of prothrombotic extracellular vesicles compared to clopidogrel" @default.
• W2981839969 doi "https://doi.org/10.1093/eurheartj/ehz747.0073" @default.
• W2981839969 hasPublicationYear "2019" @default.
• W2981839969 type Work @default.
• W2981839969 sameAs 2981839969 @default.
• W2981839969 citedByCount "0" @default.
• W2981839969 crossrefType "journal-article" @default.
• W2981839969 hasAuthorship W2981839969A5004391058 @default.
• W2981839969 hasAuthorship W2981839969A5007660537 @default.
• W2981839969 hasAuthorship W2981839969A5011053615 @default.
• W2981839969 hasAuthorship W2981839969A5018345279 @default.
• W2981839969 hasAuthorship W2981839969A5023260832 @default.
• W2981839969 hasAuthorship W2981839969A5034576499 @default.
• W2981839969 hasAuthorship W2981839969A5046792925 @default.
• W2981839969 hasAuthorship W2981839969A5048001360 @default.
• W2981839969 hasAuthorship W2981839969A5050576957 @default.
• W2981839969 hasAuthorship W2981839969A5051409613 @default.
• W2981839969 hasAuthorship W2981839969A5055422464 @default.
• W2981839969 hasAuthorship W2981839969A5059132544 @default.
• W2981839969 hasAuthorship W2981839969A5072012682 @default.
• W2981839969 hasAuthorship W2981839969A5074510402 @default.
• W2981839969 hasConcept C126322002 @default.
• W2981839969 hasConcept C164705383 @default.
• W2981839969 hasConcept C2777849778 @default.
• W2981839969 hasConcept C28406088 @default.
• W2981839969 hasConcept C2992929900 @default.
• W2981839969 hasConcept C500558357 @default.
• W2981839969 hasConcept C71924100 @default.
• W2981839969 hasConcept C86803240 @default.
• W2981839969 hasConcept C95444343 @default.
• W2981839969 hasConcept C98274493 @default.
• W2981839969 hasConceptScore W2981839969C126322002 @default.
• W2981839969 hasConceptScore W2981839969C164705383 @default.
• W2981839969 hasConceptScore W2981839969C2777849778 @default.
• W2981839969 hasConceptScore W2981839969C28406088 @default.
• W2981839969 hasConceptScore W2981839969C2992929900 @default.
• W2981839969 hasConceptScore W2981839969C500558357 @default.
• W2981839969 hasConceptScore W2981839969C71924100 @default.
• W2981839969 hasConceptScore W2981839969C86803240 @default.
• W2981839969 hasConceptScore W2981839969C95444343 @default.
• W2981839969 hasConceptScore W2981839969C98274493 @default.
• W2981839969 hasLocation W29818399691 @default.
• W2981839969 hasOpenAccess W2981839969 @default.
• W2981839969 hasPrimaryLocation W29818399691 @default.
• W2981839969 hasRelatedWork W1720452581 @default.
• W2981839969 hasRelatedWork W1974509184 @default.
• W2981839969 hasRelatedWork W1984514918 @default.
• W2981839969 hasRelatedWork W2007602661 @default.
• W2981839969 hasRelatedWork W2025730035 @default.
• W2981839969 hasRelatedWork W2040279546 @default.
• W2981839969 hasRelatedWork W2058558459 @default.
• W2981839969 hasRelatedWork W2099401845 @default.
• W2981839969 hasRelatedWork W2112053196 @default.
• W2981839969 hasRelatedWork W2320259129 @default.
• W2981839969 hasRelatedWork W2332689383 @default.
• W2981839969 hasRelatedWork W2436348978 @default.
• W2981839969 hasRelatedWork W2894838839 @default.
• W2981839969 hasRelatedWork W2979803048 @default.
• W2981839969 hasRelatedWork W2980118486 @default.
• W2981839969 hasRelatedWork W2980637923 @default.
• W2981839969 hasRelatedWork W2981362354 @default.
• W2981839969 hasRelatedWork W2981720715 @default.
• W2981839969 hasRelatedWork W3128691114 @default.
• W2981839969 hasRelatedWork W1676195785 @default.
• W2981839969 isParatext "false" @default.
• W2981839969 isRetracted "false" @default.
• W2981839969 magId "2981839969" @default.
• W2981839969 workType "article" @default.